Literature DB >> 24882969

A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea.

Seo Wan Kim1, Mi Sun Kim1, June Hyunkyung Lee1, Sook-Ja Son1, Kui Young Park2, Kapsok Li2, Seong Jun Seo2, Tae Young Han1.   

Abstract

BACKGROUND: Acquired perforating dermatosis (APD) is histopathologically characterized by transepidermal elimination of materials from the upper dermis. APD can be divided into four diseases: Kyrle's disease, perforating folliculitis, elastosis perforans serpiginosa, and reactive perforating collagenosis. APD is usually associated with systemic diseases, especially diabetes mellitus or chronic renal failure. So far, there have only been a few Korean studies of APD, which have a limited number of patients.
OBJECTIVE: The aim of this study is to evaluate the clinical and histopathologic characteristics of 30 cases of APD and to examine the association with systemic diseases.
METHODS: We retrospectively reviewed the medical records and biopsy specimens of 30 patients who were diagnosed with APD.
RESULTS: The mean age was 55.5 years, and the average duration of the lesion was 7.8 months. The lower extremities (73.3%) were the most frequently occurring sites of the lesion. Twenty-five patients (83.3%) had pruritus, and Koebner's phenomenon was present in 11 patients. Patients of 63.3% had at least one systemic disease. Diabetes mellitus (n=17, 56.7%) and chronic renal failure (n=10, 33.3%) were the most commonly associated conditions. Most patients received topical steroids (93.3%) and antihistamines (80.0%). The most common histopathologic type was reactive perforating collagenosis (n=23, 73.3%).
CONCLUSION: In this study, most patients had a systemic association to the diseases. Therefore, we suggest that further evaluation is necessary for patients who present with APD. This includes reviewing patient's comprehensive past medical history, clinical exam, and additional diagnostic testing to check for the possibility of associated systemic diseases.

Entities:  

Keywords:  Acquired perforating dermatosis; Elastosis perforans serpiginosa; Kyrle's disease; Perforating folliculitis; Reactive perforating collagenosis

Year:  2014        PMID: 24882969      PMCID: PMC4037667          DOI: 10.5021/ad.2014.26.2.162

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  23 in total

1.  Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: successful treatment with allopurinol.

Authors:  Masayuki Iyoda; Fumihiro Hayashi; Aki Kuroki; Takanori Shibata; Kozo Kitazawa; Tetsuzo Sugisaki; Osamu Sakai
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860

2.  Acquired reactive perforating collagenosis associated with myelodysplastic syndrome evolving to acute myelogenous leukaemia.

Authors:  Anthony Karpouzis; Costas Tsatalas; Efthymios Sivridis; Ioannis Kotsianidis; Dimitri Margaritis; Costas Kouskoukis; Georgios Bourikas
Journal:  Australas J Dermatol       Date:  2004-02       Impact factor: 2.875

3.  Acquired perforating dermatosis. Transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis.

Authors:  B Zelger; H Hintner; J Auböck; P O Fritsch
Journal:  Arch Dermatol       Date:  1991-05

4.  Acquired perforating dermatosis associated with pregnancy.

Authors:  R Healy; R Cerio; A Hollingsworth; A Bewley
Journal:  Clin Exp Dermatol       Date:  2009-12-08       Impact factor: 3.470

5.  Acquired perforating dermatosis: clinicopathological features in twenty-two cases.

Authors:  Y Saray; D Seçkin; B Bilezikçi
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-07       Impact factor: 6.166

6.  Kyrle's disease in patients with chronic renal failure.

Authors:  A F Hood; G L Hardegen; A R Zarate; T P Nigra; M C Gelfand
Journal:  Arch Dermatol       Date:  1982-02

7.  Kyrle-like lesions in two patients with renal failure undergoing dialysis.

Authors:  R A Stone
Journal:  J Am Acad Dermatol       Date:  1981-12       Impact factor: 11.527

8.  Acquired reactive perforating collagenosis: a clinicopathologic study of 15 cases from Saudi Arabia.

Authors:  M B Satti; A H Aref; A A Raddadi; F A Al-Ghamdi
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-02       Impact factor: 6.166

9.  Acquired perforating dermatosis in patients with chronic renal failure and diabetes mellitus.

Authors:  Seok-Beom Hong; Jung-Hun Park; Chun-Gyoo Ihm; Nack-In Kim
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

10.  Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers.

Authors:  R P Rapini; A A Herbert; C R Drucker
Journal:  Arch Dermatol       Date:  1989-08
View more
  5 in total

1.  Reactive perforating collagenosis.

Authors:  Sandeep Arora; Ajay Malik; Anil Balki
Journal:  Indian Dermatol Online J       Date:  2016 Mar-Apr

2.  Doxycycline Combined with NB-UVB Phototherapy for Acquired Reactive Perforating Collagenosis.

Authors:  Limu Gao; Lixiong Gu; Zhen Chen; Shuanglin Cao
Journal:  Ther Clin Risk Manag       Date:  2020-09-24       Impact factor: 2.423

3.  Dermoscopic findings in a case of reactive perforating collagenosis.

Authors:  Payapvipapong Kittisak; Masaru Tanaka
Journal:  Dermatol Pract Concept       Date:  2015-04-30

4.  Dermoscopy features of acquired reactive perforating collagenosis: a case series.

Authors:  Emma Ormerod; Ausama Atwan; Laszlo Intzedy; Natalie Stone
Journal:  Dermatol Pract Concept       Date:  2018-10-31

5.  Giant variant of acquired perforating dermatosis in a renal dialysis patient.

Authors:  Lauren Metterle; Cynthia M Magro; Julie B Zang
Journal:  JAAD Case Rep       Date:  2017-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.